The nuclear bile acid receptor FXR as a novel therapeutic target in cholestatic liver diseases: Hype or hope?

Hepatology

Volumn 40, Issue 1, 2004, Pages 260-263

  Trauner, Michael ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

1 NAPHTHYL ISOTHIOCYANATE; 3 [2 [2 CHLORO 4 [3 (2,6 DICHLOROPHENYL) 5 ISOPROPYL 4 ISOXAZOLYLMETHOXY]PHENYL]VINYL]BENZOIC ACID; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILE ACID; CELL NUCLEUS RECEPTOR; FARNESOID X RECEPTOR; FARNESOID X RECEPTOR STIMULATING AGENT; LACTATE DEHYDROGENASE; LIVER PROTECTIVE AGENT; TAUROURSODEOXYCHOLIC ACID; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

BILE ACID SYNTHESIS; BILE DUCT LIGATION; CELL PROLIFERATION; CHOLESTATIC LIVER DISEASE; EXTRAHEPATIC BILE DUCT OBSTRUCTION; GENE EXPRESSION; INFLAMMATORY INFILTRATE; INTRAHEPATIC CHOLESTASIS; LIVER DISEASE; LIVER PROTECTION; NONHUMAN; NOTE; PHOSPHOLIPID TRANSFER; PRIORITY JOURNAL;

EID: 3042741754     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20294     Document Type: Note

References (23)

1. Karpen SJ. Nuclear receptor regulation of hepatic function. J Hepatol 2002;36:832-850.
2. Trauner M, Boyer JL. Bile salt transporters: molecular characterization, function and regulation Physiol Rev 2003;83:633-671.
3. Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, et al. Bile acids: natural ligands for an orphan nuclear receptor. Science 1999;284:1365-1368.
4. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, et al. Identification of a nuclear receptor for bile acids. Science 1999;284:1362-1365.
5. Wang H, Chen J, Hollister K, Sowers LC, Forman BM. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 1999;3:543-553.
6. Xie W, Radominska-Pandya A, Shi Y, Simon CM, Nelson MC, Ong ES, et al. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci U S A 2001;98:3375-3380.
7. Staudinger JL, Goodwin B, Jones SA, Hawkins-Brown D, MacKenzie KI, LaTour A, et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci U S A 2001;98:3369-3374.
8. Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, et al. Vitamin D receptor as an intestinal bile acid sensor. Science 2002;296:1313-1316.
9. Neuberger J. URSO-panacea or placebo? HEPATOLOGY 2000;31:1027-1028.
10. Zollner G, Fickert P, Fuchsbichler A, Silbert D, Wagner M, Arbeiter S, et al. Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver and kidney. J Hepatol 2003;39:480-488.
11. Kim MS, Shigenaga J, Moser A, Feingold K, Grunfeld C. Repression of farnesoid X receptor during the acute phase response. J Biol Chem 2003;278:8988-8995.
12. Chen F, Ananthanarayanan M, Emre S, Neimark E, Bull LN, Knisely AS, et al. Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. Gastroenterology 2004;126:756-764.
13. Sinal JC, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000;102:731-744.
14. Wagner M, Fickert P, Zollner G, Fuchsbichler A, Silbert D, Tsybrovskyy O, et al. Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. Gastroenterology 2003;125:825-838.
15. Liu Y, Binz J, Numerick MJ, Dennis S, Luo G, Desai B, et al. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. J Clin Invest 2003;112:1678-1687.
16. Schaffner F, Scharnbeck HH, Hutterer F, Denk H, Greim HA, Popper H. Mechanism of cholestasis. VII. Naphthylisothiocyanate-induced jaundice. Lab Invest 1973;28:321-331.
17. Poo JL, Feldmann G, Erlinger S, Braillon A, Gaudin C, Dumont M, et al. Ursodeoxycholic acid limits liver histologic alterations and portal hypertension induced by bile duct ligation in the rat. Gastroenterology 1992;102:1752-1759.
18. Rius M, Nies AT, Hummel-Eisenbeiss J, Jedlitschky G, Keppler D. Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. HEPATOLOGY 2003;38:374-384.
19. Barbier O, Torra IP, Sirvent A, Claudel T, Blanquart C, Duran-Sandoval D, et al. FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity. Gastroenterology 2003;124:1926-1940.
20. Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Weiglein AH, Lammert F, et al. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology 2002;123:1238-1251.
21. Dussault I, Beard R, Lin M, Hollister K, Chen J, Xiao JH, et al. Identification of gene-selective modulators of the bile acid receptor FXR. J Biol Chem 2003;278:7027-7033.
22. Guo GL, Lambert G, Negishi M, Ward JM, Brewer HB Jr, Kliewer SA, et al. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J Biol Chem 2003;278:45062-45071.
23. Dubuquoy L, Dharancy S, Nutten S, Pettersson S, Auwerx J, Desreumaux P. Role of peroxisome proliferator-activated receptor gamma and retinoid X receptor heterodimer in hepatogastroenterological diseases. Lancet 2002;360:1410-1418.